Pressure BioSciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies - Schedule of Fair Value Assumptions (Details)

Summary of Significant Accounting Policies - Schedule of Fair Value Assumptions (Details) - $ / shares	6 Months Ended	12 Months Ended
	Jun. 30, 2017	Dec. 31, 2016
Issuance Fair Value [Member] \| Minimum [Member]
Expected life (in months)	6 months
Expected volatility	104.20%
Risk-free interest rate	0.05%
Exercise price	$ 3.00
Fair value per share	$ 2.70
Issuance Fair Value [Member] \| Maximum [Member]
Expected life (in months)	24 months
Expected volatility	153.80%
Risk-free interest rate	0.99%
Exercise price	$ 0.50
Fair value per share	$ 8.40
Issuance Fair Value [Member] \| Warrants Issued with Convertible Debt [Member]
Expected life (in months)	60 months
Exercise price	$ 12.00
Issuance Fair Value [Member] \| Warrants Issued with Convertible Debt [Member] \| Minimum [Member]
Expected volatility	118.30%
Risk-free interest rate	1.48%
Fair value per share	$ 5.70
Issuance Fair Value [Member] \| Warrants Issued with Convertible Debt [Member] \| Maximum [Member]
Expected volatility	120.10%
Risk-free interest rate	1.69%
Fair value per share	$ 6.30
Warrants Revalued at December 31, 2016 [Member] \| Warrants Issued with Convertible Debt [Member]
Risk-free interest rate		1.93%
Exercise price		$ 12.00
Warrants Revalued at December 31, 2016 [Member] \| Warrants Issued with Convertible Debt [Member] \| Minimum [Member]
Expected life (in months)		43 months
Expected volatility		110.00%
Fair value per share		$ 3.60
Warrants Revalued at December 31, 2016 [Member] \| Warrants Issued with Convertible Debt [Member] \| Maximum [Member]
Expected life (in months)		51 months
Expected volatility		116.00%
Fair value per share		$ 4.20
Warrants Revalued at June 30, 2017 [Member] \| Warrants Issued with Convertible Debt [Member]
Risk-free interest rate	1.50%
Exercise price	$ 12.00
Warrants Revalued at June 30, 2017 [Member] \| Warrants Issued with Convertible Debt [Member] \| Minimum [Member]
Expected life (in months)	36 months
Expected volatility	104.10%
Fair value per share	$ 4.16
Warrants Revalued at June 30, 2017 [Member] \| Warrants Issued with Convertible Debt [Member] \| Maximum [Member]
Expected life (in months)	45 months
Expected volatility	108.50%
Fair value per share	$ 4.77
At Settlement Fair Value [Member] \| Minimum [Member]
Expected life (in months)	0 months
Expected volatility	86.90%
Risk-free interest rate	0.01%
Exercise price	$ 3.00
Fair value per share	$ 2.10
At Settlement Fair Value [Member] \| Maximum [Member]
Expected life (in months)	18 months
Expected volatility	142.20%
Risk-free interest rate	0.72%
Exercise price	$ 7.50
Fair value per share	7.80
Conversion Options Revalued at December 31, 2016 [Member]
Exercise price		$ 8.40
Conversion Options Revalued at December 31, 2016 [Member] \| Minimum [Member]
Expected life (in months)		6 months
Expected volatility		84.40%
Risk-free interest rate		0.62%
Fair value per share		$ 0.90
Conversion Options Revalued at December 31, 2016 [Member] \| Maximum [Member]
Expected life (in months)		15 months
Expected volatility		94.80%
Risk-free interest rate		0.85%
Fair value per share		$ 1.80
Conversion Options Revalued at June 30, 2017 [Member]
Exercise price	$ 8.40
Conversion Options Revalued at June 30, 2017 [Member] \| Minimum [Member]
Expected life (in months)	1 month
Expected volatility	88.20%
Risk-free interest rate	0.84%
Fair value per share	$ 0.28
Conversion Options Revalued at June 30, 2017 [Member] \| Maximum [Member]
Expected life (in months)	9 months
Expected volatility	104.30%
Risk-free interest rate	1.24%
Fair value per share	$ 2.14